Availability of the new IgM blood test on the ARCHITECT and Alinity platforms is part of Abbott's effort to offer tests across the disease progression of COVID-19
The CTS Rotea system aims to help researchers overcome manufacturing hurdles and bring the vast potential of cell therapies to more patients
Find out how experts at the Ellison Institute are harnessing new cell monitoring technology to build cancer cell biobanks and enhance cell line quality control and authentication
Partnership combines Twist’s leadership in DNA synthesis and synthetic biology with Neogene’s expertise in personalized engineered T cell therapies
Antibodies available are specific for S1, S2 and receptor-binding domain regions of SARS-CoV-2 Spike protein
The CleanPlex ACE2 & TMPRSS2 Panel assesses differences in patients’ genetic susceptibility to COVID-19 infection and to developing severe disease
Combination test for COVID-19, flu and other common respiratory illnesses helps health care professionals prepare for flu season
The addition of COVID-19 antibody tests to the portfolio aims to further support the pandemic response on multiple fronts
Access SARS-CoV-2 IgG assay shows excellent agreement with the Genscript Surrogate Virus Neutralization Test
Samples from the lungs of patients show a runaway immune system reaction could be one mechanism behind severe COVID-19 cases
Fluidigm COVID-19 campus safeguard program improves availability of non-invasive, saliva-based SARS-CoV-2 tests for higher education institutions
Harvey J. Alter, Michael Houghton, and Charles M. Rice are joint winners of 2020 Nobel Prize for medicine
Researchers have made a significant COVID-19 drug target discovery using Thermo Fisher Scientific CryoEM technology
Affimer-based research assay launched alongside performance data published by Bruker
Join thousands of scientists from around the world as they come together online to discuss the hottest topics and latest technology solutions in the field
Early surgical treatment of leg ulcers caused by varicose veins improves healing and reduces the risk of the condition coming back
Menu of test solutions for infectious diseases – which already includes COVID-19 – to be expanded, especially in the U.S.
Promega and Incyte intend to work together in the future to develop the Promega OncoMate MSI Assay as a companion diagnostic
The Direct assay is validated on a wide range of specimen types, and can be run in parallel with the Simplexa Flu A/B & RSV Direct Gen II assay
cPass is first commercially available product to rapidly detect neutralizing antibodies capable of eliminating virus
The new line aims to provide unmatched sensitivity, resolution, speed, and flexibility of colors
Emergency scans captured images of the top of the lungs where a fluffiness known as ‘ground glass opacification’ allowed COVID-19 to be diagnosed
AstraZeneca anticipates entering clinical development in 2021
